SCHEMBL5342156

SCHEMBL5342156

Cc1c(Cl)cccc1S(=O)(=O)Nc1ccc2ncccc2c1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC40A1 Q9NP59 3/20 0.62
ALDH1A1 P00352 2/20 0.61
LMNA P02545 2/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
MEN1 O00255 4/20 0.60
KMT2A Q03164 4/20 0.60
EDNRB P24530 2/20 0.53
EDNRA P25101 2/20 0.53
HSD11B1 P28845 2/20 0.52
PKM P14618 1/20 0.50
CYP3A4 P08684 1/20 0.49
PPARG P37231 1/20 0.49
ATM Q13315 1/20 0.48
CCR4 P51679 1/20 0.47
ALPL P05186 1/20 0.47
THRB P10828 1/20 0.47
HPGD P15428 1/20 0.47
PKLR P30613 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5343634 0.86 EDNRB (0.53) SLC40A1ALDH1A1LMNAMEN1KMT2A
SCHEMBL5343689 0.84 HSD11B1 (0.60) SLC40A1ALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL5344543 0.84 HSD11B1 (0.50) SLC40A1ALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL6984890 0.83 ALDH1A1 (0.67) SLC40A1ALDH1A1LMNASMN1; SMN2MEN1
SCHEMBL5338606 0.81 HSD11B1 (0.55) SLC40A1ALDH1A1LMNAMEN1KMT2A
SCHEMBL5377995 0.81 ALPL (0.72) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL6981195 0.80 ALDH1A1 (0.60) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL5337572 0.80 HSD11B1 (0.54) SLC40A1ALDH1A1LMNAMEN1KMT2A
SCHEMBL617881 0.78 LMNA (0.62) ALDH1A1LMNASMN1; SMN2MEN1KMT2A
SCHEMBL618169 0.78 HSD11B1 (0.51) SLC40A1ALDH1A1LMNASMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-7230020-B2 11β-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2007-06-12 US disclosed
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors STERIX LIMITED (GB) 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050227987-A1 11beta-hydroxysteroid dehydrogenase inhibitors HSD3B1, HSD3B2, HSD17B3 SLC40A1 4120/4885ALDH1A1 378/4885LMNA 646/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.